Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
28 hedge funds and large institutions have $8.08M invested in Lumos Pharma, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 9 closing their positions.
68% more capital invested
Capital invested by funds: $4.82M → $8.08M (+$3.26M)
20% less funds holding
Funds holding: 35 → 28 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$1.98M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$27.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$18.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$969K |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$328K |
| 3 |
LPC
Lion Point Capital
New York
|
-$142K |
| 4 |
Goldman Sachs
New York
|
-$123K |
| 5 |
Millennium Management
New York
|
-$85.9K |
LUMO Hedge Fund Activity: Q3 2024 in Review
28 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q3 2024, worth a combined $8.08M — up 68% from $4.82M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LUMO and 2 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 2 added.
The largest buyer was Private Advisor Group, adding an estimated $1.98M. The largest seller was Wells Fargo, cutting an estimated $969K.
- 28 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q3 2024, down from 35 in Q2 2024.
- Funds reported $8.08M of Lumos Pharma, Inc. Common Stock stock for Q3 2024, up 68% quarter-over-quarter.
- 2 funds opened new Lumos Pharma, Inc. Common Stock positions in Q3 2024 and 9 closed out, a net change of -7 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q3 2024 was Private Advisor Group, an estimated $1.98M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q3 2024 was Wells Fargo, an estimated $969K sold.
Based on aggregated 13F filings for Q3 2024.